These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10282344)

  • 1. Organized interests in health politics and policy-making.
    Tierney JT
    Med Care Rev; 1987; 44(1):89-118. PubMed ID: 10282344
    [No Abstract]   [Full Text] [Related]  

  • 2. Dealing with the conflict of interests in health care reform.
    Hale MM
    J Health Hum Serv Adm; 1998; 21(2):162-80. PubMed ID: 10538061
    [No Abstract]   [Full Text] [Related]  

  • 3. Organized medicine's united front in Washington is showing more cracks.
    Kosterlitz J
    Natl J (Wash); 1986 Jan; 18(2):82-6. PubMed ID: 10274943
    [No Abstract]   [Full Text] [Related]  

  • 4. Wish lists: 1999 lobbying outlook.
    Meyer H
    Hosp Health Netw; 1999 Jan; 73(1):64-6, 68, 70-2. PubMed ID: 10067161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interest groups turning to ads to make pitch for, against reform.
    Burns J
    Mod Healthc; 1993 Oct; 23(40):60. PubMed ID: 10128505
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of interest group influence on federal school meals regulations 1992 to 1996.
    Hobbs SH; Ricketts TC; Dodds JM; Milio N
    J Nutr Educ Behav; 2004; 36(2):90-8. PubMed ID: 15068758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The health lobby: making private interest public law. Part II.
    Sorian R
    New Physician; 1984 Dec; 33(9):28-9, 38-9. PubMed ID: 10269508
    [No Abstract]   [Full Text] [Related]  

  • 8. Wish list 2000. Interview by Terese Hudson Thrall.
    Pollack R; Rother J; Reardon T; Ignagni K
    Hosp Health Netw; 2000 Jan; 74(1):49-50. PubMed ID: 11387748
    [No Abstract]   [Full Text] [Related]  

  • 9. The elderly as a political force--26 million strong and well organized.
    Peirce NR; Choharis PC
    Natl J (Wash); 1982 Sep; 14(37):1559-62. PubMed ID: 10256459
    [No Abstract]   [Full Text] [Related]  

  • 10. Well-healed: inside lobbying for health care reform, Part III.
    Int J Health Serv; 1996; 26(1):19-46. PubMed ID: 8932600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Washington wish list. Interview by Dagmara Sarudi, Terese Hudson Thrall, Richard Haugh, Joyce Kelly.
    Pollack R; Smoak RD; Ignagni K; Smith PP; Lehman G; Gonzalez R; Kloss L
    Hosp Health Netw; 2001 Feb; 75(2):62-4, 66, 68. PubMed ID: 11236607
    [No Abstract]   [Full Text] [Related]  

  • 12. Newtral actions.
    Serafini MW
    Natl J (Wash); 1995 Nov; 27(47):2918-22. PubMed ID: 10154546
    [No Abstract]   [Full Text] [Related]  

  • 13. The shaping of health care policy.
    Gottlieb KC
    Manag Care; 2002 Jul; 11(7 Suppl):4-7; discussion 7. PubMed ID: 12181874
    [No Abstract]   [Full Text] [Related]  

  • 14. Industry PACs donate thousands to "maintain access" to legislators.
    Baldwin M
    Mod Healthc; 1986 Oct; 16(22):35. PubMed ID: 10279072
    [No Abstract]   [Full Text] [Related]  

  • 15. The ailing AMA. The doctors' lobby is struggling to recruit members and retain its status as a Washington powerhouse.
    Carney EN
    Natl J (Wash); 1998 Oct; 30(40):2300-4. PubMed ID: 10185193
    [No Abstract]   [Full Text] [Related]  

  • 16. As healthcare groups help fill campaign coffers, the question is: what is the money buying?
    Wagner L; Weissenstein E
    Mod Healthc; 1992 Nov; 22(44):38-40. PubMed ID: 10122168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new game ahead? Experts ponder prospect of congressional term limits.
    Blankenau R
    Hospitals; 1993 Feb; 67(3):32-5. PubMed ID: 8425736
    [No Abstract]   [Full Text] [Related]  

  • 18. Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018.
    Wouters OJ
    JAMA Intern Med; 2020 May; 180(5):688-697. PubMed ID: 32125357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niche players in health policy: medical specialty societies in Congress 1969-2002.
    Rabinowitz A; Laugesen M
    Soc Sci Med; 2010 Oct; 71(7):1341-1348. PubMed ID: 20702014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grassroots lobbying: an important tool for pharmacy. Lobbying can lead to acknowledgment as health care providers.
    Lipowski E
    J Am Pharm Assoc (2003); 2004; 44(1):6-7. PubMed ID: 15008167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.